Stocktoria
Hyperfine, Inc. HYPR
Hyperfine, Inc. (HYPR) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $13.6M at a -262.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.5 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.709 |
| Retained earnings / assets | -5.972 |
| EBIT / assets | -0.671 |
| Equity / liabilities | 2.876 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| HYPR | Hyperfine, Inc. | 4/9 | -16.31 | — | +5.2% |
| CV | CapsoVision, Inc | 2/9 | — | — | +15.3% |
| NUWE | Nuwellis, Inc. | 2/9 | — | — | — |
| QTI | QT IMAGING HOLDINGS, INC. | 5/9 | -4.34 | — | — |
| POCI | PRECISION OPTICS CORPORATION, INC. | 3/9 | -8.27 | — | -0.1% |
| NRXS | Neuraxis, INC | 3/9 | — | — | — |
| HCIL | Hongchang International Co., Ltd | 2/9 | 2.23 | — | — |
About Hyperfine, Inc.
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
FAQ
Is HYPR financially healthy?
Hyperfine, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does HYPR pay a dividend?
No, Hyperfine, Inc. does not currently pay a dividend.
How profitable is HYPR?
In FY2025, Hyperfine, Inc. had a net margin of -262.3% and a return on equity of -86.8%.
What is the analyst price target for HYPR?
The average Wall-Street price target for Hyperfine, Inc. is $2.17, about 140.6% above the recent price, from 3 analysts.
Is HYPR a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Hyperfine, Inc.: a Piotroski F-score of 4/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.